Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the clinical efficacy of traditional Chinese medicine in the treatment of asthma, and to promote the application in community hospitals.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Shanghai University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• Patients had positive bronchodilator reversibility test or positive bronchial challenge test or more than 50 parts per billion of FENO before

• Number of months without control between 1 and 3 months last year

• The course of asthma was more than 10 years and less than 30 years

• Conform to the predetermined 4 TCM Syndrome Types

• Patients who have given written informed consent

Exclusion Criteria:

• Smoking and continuous exposure to hazardous environment

• With fever, or severity of intermittent state, high degree of sustained, or with respiratory failure, etc.

• Long term inhaled corticosteroids (more than 5 years) prior to study entry

• Pulmonary emphysema, chronic obstructive pulmonary disease, pulmonary emphysema, pulmonary heart disease, pneumonia, lung cancer and other lung diseases

• Rheumatic immune disease, diabetes, hyperthyroidism, menopause, gastroesophageal reflux, arrhythmia and other complications of the disease

• Heart, liver, kidney and other organ dysfunction

• Accompanied by other diseases of long-term use of glucocorticoids, anti allergy drugs, mental or neurological drugs or traditional Chinese Medicine

• Patients who are allergic to therapeutic medicine

• Female patients in lactation period, pregnancy or planning to get pregnant during the trial

• Patients with mental or neurological disorders